Crossject USA: new appointment

Image de l'actualité
Date de parution
Contenu texte de l'actualité

Crossject appoints Don Zinn as VP US Business. Don brings 25 years of experience in building biotech, pharmaceutical and medical device companies from benchtop to the marketplace. He has been in charge of business strategies, fundraising and executed multiple deals.
Most recently, Don was the US Head of Innovation for Rentschler Biopharma. He also volunteers as a mentor for the University of Michigan Coulter Translational Research Partnership, the Western Michigan Medical School Innovation Center, and at the National Institutes of Health (NIH).
Don has been consulting with Crossject Business Development team for the past four months and is very excited to join the company.